Apolipoprotein assessment typically encompasses measurement of Apolipoprotein B (ApoB) and Apolipoprotein A-I (ApoA-I), the primary structural proteins of atherogenic and cardioprotective lipoproteins, respectively. These measurements provide a more direct quantification of lipoprotein particle number and function than traditional lipid panels. The ApoB/ApoA-I ratio is increasingly recognized as a superior predictor of cardiovascular risk compared to conventional LDL-cholesterol measurements. ApoB is the obligatory structural protein found on all atherogenic lipoprotein particles—including LDL, VLDL, IDL, and Lp(a)—with each particle carrying exactly one ApoB molecule, making its concentration a direct measure of atherogenic particle number. ApoA-I is the major protein component of HDL particles and plays a central role in reverse cholesterol transport, facilitating the removal of excess cholesterol from peripheral tissues to the liver. The balance between these two apolipoproteins reflects the net atherogenic burden and cardioprotective capacity of the circulating lipoprotein milieu.
Apolipoproteins are proteins that carry cholesterol and fats through your bloodstream. ApoB is found on the 'bad' cholesterol particles that can build up in artery walls, while ApoA-I is found on 'good' cholesterol particles that help remove cholesterol from your arteries. Measuring these proteins gives your doctor a more precise picture of your heart disease risk than a standard cholesterol test alone. High ApoB or a high ApoB-to-ApoA-I ratio may suggest a greater risk for heart attack or stroke, while favorable levels are reassuring. Your doctor will use these results alongside your other health information to guide any necessary lifestyle or medical interventions.
When elevated: Elevated ApoB indicates an increased number of circulating atherogenic lipoprotein particles, associated with heightened risk of atherosclerotic cardiovascular disease, coronary artery disease, and ischemic stroke. A low ApoA-I level suggests reduced reverse cholesterol transport capacity and is independently associated with increased cardiovascular risk. When low: Low ApoB levels generally indicate a reduced atherogenic lipoprotein burden and are associated with lower cardiovascular risk; however, very low levels may occasionally be seen in malnutrition, hyperthyroidism, or rare genetic conditions such as abetalipoproteinemia. Elevated ApoA-I is generally favorable, reflecting robust HDL-mediated reverse cholesterol transport, though extremely high levels may not confer proportionally greater benefit.
Apolipoprotein assessment is relevant to athletes pursuing long-term cardiovascular health and longevity rather than acute performance. High training volume can temporarily alter lipid profiles; ApoB and ApoA-I measurements help distinguish true atherogenic risk from transient lipid shifts caused by intense exercise, informing whether dietary or training adjustments are needed to maintain cardiovascular protection during peak training phases.
Turnaround Time
3 days (up to 13 days)
Fasting Required
No
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$29.00$85
2.9× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$29.00
$29.00
$90.00
Peer-reviewed sources supporting the educational content on this page.